Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness

被引:142
作者
Robbins, CS
Dawe, DE
Goncharova, SI
Pouladi, MA
Drannik, AG
Swirski, FK
Cox, G
Stämpfli, MR
机构
[1] McMaster Univ, Hlth Sci Ctr, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Ctr Gene Therapeut, Hamilton, ON L8N 3Z5, Canada
[3] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada
关键词
D O I
10.1165/rcmb.2003-0259OC
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the impact of cigarette smoke exposure on respiratory immune defense mechanisms. Mice were exposed to two cigarettes daily, 5 d/wk, for 2-4 mo. Tobacco smoke decreased the number of dendritic cells (DCs) in the lung tissue. Furthermore, smoke exposure dramatically reduced the percentage of B7.1-expressing DCs. Because DCs are believed to be indispensable to the initiation of adaptive immune responses, we investigated the impact of cigarette smoke on immune responsiveness toward adenovirus. Mice were exposed to two cigarettes for 2-4 mo and inoculated with 2 X 10(8) pfu of a replication-deficient adenovirus on three occasions, 2 wk apart, during the last month of tobacco smoke exposure. Smoke exposure specifically prevented the expansion and maximal activation of CD4 T cells and reduced the number of both activated CD4 and CD8 T cells. Consequently, smoke exposure shifted the activated CD4:CD8 T cell ratio from 3 to 1.5 when compared with sham exposure. Significant decreases were also observed in serum adenovirus-specific pan IgG, IgG1, and IgG2a immunoglobulin levels, which was associated with diminished viral neutralization capacity. We demonstrate that chronic tobacco smoke exposure impairs the immune response against adenovirus. This may, in part, explain the increased prevalence of viral infections in chronic obstructive pulmonary disease.
引用
收藏
页码:202 / 211
页数:10
相关论文
共 63 条
[1]   ANTIBODIES TO HEN AND DUCK ANTIGENS IN POULTRY WORKERS [J].
ANDERSEN, P ;
SCHONHEYDER, H .
CLINICAL ALLERGY, 1984, 14 (05) :421-428
[2]  
ANDERSEN P, 1982, CLIN EXP IMMUNOL, V47, P467
[3]  
ANDERSEN P, 1983, ACTA MED SCAND, V213, P191
[4]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[5]  
BACHMANN MF, 1994, J IMMUNOL, V153, P3386
[6]   New therapies for chronic obstructive pulmonary disease [J].
Barnes, PJ .
THORAX, 1998, 53 (02) :137-147
[7]   AN EFFICIENT AND FLEXIBLE SYSTEM FOR CONSTRUCTION OF ADENOVIRUS VECTORS WITH INSERTIONS OR DELETIONS IN EARLY REGION-1 AND REGION-3 [J].
BETT, AJ ;
HADDARA, W ;
PREVEC, L ;
GRAHAM, FL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :8802-8806
[8]   The relationship of childhood respiratory infection to growth and decline in lung function [J].
Britton, J ;
Martinez, FD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (06) :S240-S245
[9]   TOBACCO-SMOKE SUPPRESSES T-CELLS BUT NOT ANTIGEN-PRESENTING CELLS IN THE LUNG-ASSOCIATED LYMPH-NODES [J].
CHANG, JCC ;
DISTLER, SG ;
KAPLAN, AM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1990, 102 (03) :514-523
[10]   Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease [J].
Collet, JP ;
Shapiro, S ;
Ernst, P ;
Renzi, P ;
Ducruet, T ;
Robinson, A ;
Gauthier, G ;
Beaupre, A ;
Gregoire, P ;
Jacquemin, P ;
Plante, F ;
Lachance, Y ;
Provost, G ;
Hernandez, P ;
JeanFrancois, R ;
Charbonneau ;
Inhaber, N ;
Braidy, J ;
Jeanneret, A ;
Bolduc, P ;
Leblanc, PP ;
Olivenstein, R ;
Mannix, S ;
Chrysler, B ;
Wolkove, N ;
Kreisman, H ;
Frank ;
Fox, J ;
Colman, N ;
Gruber, J ;
Zidulka ;
Gursahaney, A ;
Matouk ;
Eidelman, D ;
Julien, M ;
Malo, J ;
Dandurand, R ;
Skamene, E ;
Suissa, S ;
Choi, S ;
Martin, J ;
Dankoff, G ;
Enjalbert, M ;
Lauener, PA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (06) :1719-1724